Primary |
Drug Use For Unknown Indication |
29.5% |
Drug Exposure During Pregnancy |
16.2% |
General Anaesthesia |
13.2% |
Anaesthesia |
9.0% |
Induction Of Anaesthesia |
7.7% |
Product Used For Unknown Indication |
2.6% |
Sedation |
2.6% |
Analgesic Therapy |
2.1% |
Occupational Exposure To Drug |
2.1% |
Asthma |
1.7% |
Circumcision |
1.7% |
Maintenance Of Anaesthesia |
1.7% |
Poor Quality Sleep |
1.7% |
Prophylaxis |
1.7% |
Stupor |
1.7% |
Premedication |
1.3% |
Bronchospasm |
0.9% |
Epidural Anaesthesia |
0.9% |
Hysterectomy |
0.9% |
Mastectomy |
0.9% |
|
Drug Exposure During Pregnancy |
27.8% |
Congenital Anomaly |
22.2% |
Drug Ineffective |
6.9% |
Therapeutic Agent Toxicity |
5.6% |
Intentional Drug Misuse |
4.2% |
Myocardial Infarction |
4.2% |
Cardiac Arrest |
2.8% |
Congenital Eye Disorder |
2.8% |
Death |
2.8% |
Hypersensitivity |
2.8% |
Overdose |
2.8% |
Poor Quality Drug Administered |
2.8% |
Rhabdomyolysis |
2.8% |
Atrioventricular Block |
1.4% |
Drug Withdrawal Syndrome |
1.4% |
Hepatic Failure |
1.4% |
Hyperthermia Malignant |
1.4% |
Intentional Overdose |
1.4% |
Intracranial Pressure Increased |
1.4% |
Kounis Syndrome |
1.4% |
|
Secondary |
Drug Use For Unknown Indication |
47.1% |
General Anaesthesia |
14.9% |
Anaesthesia |
10.7% |
Antiphospholipid Syndrome |
3.3% |
Asthma |
3.3% |
Product Used For Unknown Indication |
2.5% |
Sedation |
2.5% |
Anaesthesia Reversal |
1.7% |
Analgesic Therapy |
1.7% |
Idiopathic Thrombocytopenic Purpura |
1.7% |
Induction Of Anaesthesia |
1.7% |
Neuralgia |
1.7% |
Poor Quality Sleep |
1.7% |
Analgesia |
0.8% |
Antiemetic Supportive Care |
0.8% |
Bipolar Disorder |
0.8% |
Induction And Maintenance Of Anaesthesia |
0.8% |
Long Qt Syndrome |
0.8% |
Mastectomy |
0.8% |
Musculoskeletal Pain |
0.8% |
|
Sinus Tachycardia |
15.0% |
Therapeutic Agent Toxicity |
10.0% |
Twin Pregnancy |
10.0% |
Urinoma |
10.0% |
Angle Closure Glaucoma |
5.0% |
Atrioventricular Block |
5.0% |
Bronchospasm |
5.0% |
Drug Ineffective |
5.0% |
Hypoxic Encephalopathy |
5.0% |
Intentional Overdose |
5.0% |
Intracranial Pressure Increased |
5.0% |
Jaundice |
5.0% |
Premature Rupture Of Membranes |
5.0% |
Procedural Pain |
5.0% |
Torsade De Pointes |
5.0% |
|
Concomitant |
Product Used For Unknown Indication |
63.5% |
Drug Use For Unknown Indication |
13.5% |
Coronary Artery Bypass |
6.7% |
Aortic Valve Replacement |
2.6% |
Catheterisation Cardiac |
1.7% |
Mitral Valve Replacement |
1.5% |
Mitral Valve Repair |
1.2% |
Asthma |
1.2% |
Cardiac Operation |
0.9% |
Surgery |
0.9% |
Cardiac Failure |
0.9% |
Infection |
0.7% |
Respiratory Disorder |
0.7% |
Procedural Pain |
0.7% |
Continuous Haemodiafiltration |
0.6% |
Gastrointestinal Haemorrhage |
0.6% |
Intravenous Catheter Management |
0.6% |
Sedation |
0.6% |
Arteriogram Coronary |
0.5% |
Mitral Valve Disease Mixed |
0.5% |
|
Injury |
12.3% |
Pain |
10.1% |
Fear |
9.4% |
Unevaluable Event |
8.7% |
Renal Failure |
7.2% |
Renal Injury |
7.2% |
Anhedonia |
5.8% |
Emotional Distress |
5.8% |
Renal Failure Acute |
5.1% |
Anxiety |
4.3% |
Depression |
3.6% |
Renal Impairment |
3.6% |
Death |
2.9% |
Fear Of Death |
2.2% |
Multi-organ Failure |
2.2% |
Psychiatric Symptom |
2.2% |
Vascular Resistance Systemic Decreased |
2.2% |
Ventricular Tachycardia |
2.2% |
Disseminated Intravascular Coagulation |
1.4% |
Drug Effect Decreased |
1.4% |
|